×
About 270 results

ALLMedicine™ First-degree Atrioventricular Block Center

Research & Reviews  71 results

Long-term open-label and real-world studies of lasmiditan, ubrogepant, and rimegepant f...
https://doi.org/10.1177/03331024221137092
Cephalalgia : an International Journal of Headache; Begasse de Dhaem O, Takizawa T et. al.

Feb 6th, 2023 - Long-term data helps assess the consistency of efficacy, tolerability, and safety of acute treatment over repeated use for different attacks. Real-world studies help assess tolerability, safety, and efficacy in patients with possibly refractory ch...

Lifestyle habits associated with cardiac conduction disease.
https://doi.org/10.1093/eurheartj/ehac799
European Heart Journal; Frimodt-Møller EK, Soliman EZ et. al.

Jan 21st, 2023 - Cardiac conduction disease can lead to syncope, heart failure, and death. The only available therapy is pacemaker implantation, with no established prevention strategies. Research to identify modifiable risk factors has been scant. Data from the C...

Dose of Magnesium Sulfate Infusion in Obese
https://clinicaltrials.gov/ct2/show/NCT04645719

Nov 4th, 2022 - After approval by the Research Ethics Committee and registration of the project at ClinicalTrials (www.ClinicalTrials.gov) 75 patients will be selected from a population of obese patients scheduled for laparoscopic, bariatric or cholecystectomy su...

Minimally invasive versus sternotomy approach for double-patch repair of partial anomal...
https://doi.org/10.1111/jocs.17093
Journal of Cardiac Surgery; Amirghofran AA, Nirooei E et. al.

Nov 3rd, 2022 - Several surgical techniques have been proposed to repair right partial anomalous pulmonary venous connection (PAPVC) along with sinus venosus defect (SVD). This study aimed to compare the perioperative data and outcomes of double-patch repair usin...

Adalimumab for the treatment of cardiac sarcoidosis with multiple arrhythmias.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9773717
ESC Heart Failure; Li S, Wang H et. al.

Sep 1st, 2022 - A 45-year-old male with cardiac sarcoidosis verified by cardiac biopsy presented with multiple coexisting arrhythmias, including ventricular tachycardia of more than 1000 episodes per 24 h, paroxysmal atrial fibrillation, and third-degree atrioven...

see more →

Drugs  19 results see all →

Clinicaltrials.gov  3 results

Dose of Magnesium Sulfate Infusion in Obese
https://clinicaltrials.gov/ct2/show/NCT04645719

Nov 4th, 2022 - After approval by the Research Ethics Committee and registration of the project at ClinicalTrials (www.ClinicalTrials.gov) 75 patients will be selected from a population of obese patients scheduled for laparoscopic, bariatric or cholecystectomy su...

ReachPR Trial Resynchronization Therapy in Heart Failure Patients With Prolonged PR Interval
https://clinicaltrials.gov/ct2/show/NCT03973944

Aug 14th, 2019 - Rationale: Prolongation of the electrocardiographic PR interval (PR interval > 200ms; also known as first-degree atrioventricular block) is frequently encountered in clinical practice and is generally considered as a benign sign. However, there is...

Cohort Description of Younger With AV-block
https://clinicaltrials.gov/ct2/show/NCT03024047

Jan 18th, 2017 - Method: The following covariates will be reported. Date of diagnosis of AV-block: The date of diagnosis is defined as the day the physician diagnoses the AV-block. E.g. if the patient has a Holter monitoring performed, the date of diagnosis is the...

see more →

News  15 results

Ibrutinib/Rituximab Combo Represents Effective Chemo-Free Option for Elderly Patients with MCL
https://www.onclive.com/view/ibrutinib-rituximab-combo-represents-effective-chemo-free-option-for-elderly-patients-with-mcl

Jan 14th, 2022 - The combination of ibrutinib (Imbruvica) and rituximab (Rituxan) produced a high overall response rate (ORR) and durable survival in elderly patients with mantle cell lymphoma (MCL), according to data from a phase 2 ENRICH trial (NCT0180567) publi...

One Aducanumab Patient, Six Brain Edema Episodes
https://www.medpagetoday.com/neurology/alzheimersdisease/95523

Nov 8th, 2021 - A man treated with the recently approved Alzheimer's drug aducanumab (Aduhelm) had six amyloid-related imaging abnormality (ARIA) episodes, researchers reported. Over 44 months in a long-term extension study, the Alzheimer's disease patient had re...

New-Onset Arrhythmia After TAVR: How New, Really?
https://www.medpagetoday.com/cardiology/pci/87583

Jul 15th, 2020 - Week-long continuous ECG monitoring was a worthwhile addition to the workup before transcatheter aortic valve replacement (TAVR), a small study suggested. Monitoring with the wearable CardioSTAT device over 7 days revealed arrhythmic events in 51 ...

Relapsing MS: Ozanimod Tops Fingolimod in Benefit-Risk Profile
https://www.mdedge.com/neurology/msresourcecenter/article/217365/multiple-sclerosis/relapsing-ms-ozanimod-tops-fingolimod?channel=251

Feb 14th, 2020 - Key clinical point: Ozanimod has a superior benefit-risk profile compared with fingolimod for the treatment of relapsing multiple sclerosis (RMS). Major finding: Compared with fingolimod, ozanimod was associated with lower rates of conduction abno.

Relapsing MS: Ozanimod Tops Fingolimod in Benefit-Risk Profile
https://www.mdedge.com/neurology/msresourcecenter/article/217365/multiple-sclerosis/relapsing-ms-ozanimod-tops-fingolimod

Feb 14th, 2020 - Key clinical point: Ozanimod has a superior benefit-risk profile compared with fingolimod for the treatment of relapsing multiple sclerosis (RMS). Major finding: Compared with fingolimod, ozanimod was associated with lower rates of conduction abno.

see more →